Morcellation of the Uterus: Is There Any Place?
Clicks: 193
ID: 273950
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
4.8
/100
16 views
16 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In 2014, the US Food and Drug Administration (FDA) issued a safety communication warning against the use of laparoscopic power morcellators. A risk of occult uterine sarcoma in women is 1/770 to 1/10,000. Our goal is to minimize the risk of spillage due to morcellation and balance it with other risk …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (48 words).
Try re-searching for a better abstract.
| Reference Key |
mj2020currentmorcellation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Halaska MJ;Gracia M;Laky R;Zapardiel I;; |
| Journal | Current oncology reports |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
laparoscopy
ignacio zapardiel
pmid:32514869
doi:10.1007/s11912-020-00927-6
michael j halaska
myriam gracia
morcellation / adverse effects*
morcellation / methods
sarcoma / etiology
uterine myomectomy / adverse effects*
uterine neoplasms / etiology
uterus / surgery*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.